Model
Edge
Five Prime Therapeutics, Inc.
0001175505
Filing type
SC 13G/A
Filing date
Feb 14, 2022
Updated
Feb 14, 2022 ยท 11:26 AM
Copy reference
Filing
SC 13G/A
Amended Schedule 13G - Ownership Report